首页> 外国专利> It reacted uniquely production method of the anti- human fibrin monomer unique monoclonal antibody and the said monoclonal antibody, the hybridoma and

It reacted uniquely production method of the anti- human fibrin monomer unique monoclonal antibody and the said monoclonal antibody, the hybridoma and

机译:抗人纤维蛋白单体独特单克隆抗体与所述单克隆抗体,杂交瘤和

摘要

The use of the active fibrin, a native fibrin monomer occurring at an early stage of blood coagulation, a monoclonal antibody capable of detecting soluble fibrin, hybridoma, and its monoclonal antibody To provide a sensitive and rapid measurement method for early stage of blood coagulation formation. A fibrin monomer similar to the blood fibrin monomer is used as an immunogen, and is not reactive to fibrinogen by a cell fusion method, and is contained in a native fibrin monomer Monoclonal antibodies that can be recognized simultaneously and soluble fibrin were identified. The fibrin monomer analogous compound is preferably fibrin gen, which is treated with a baton monomer similar compound, which is treated with a batroxobine ("poison").
机译:活性血纤蛋白,凝血早期出现的天然血纤蛋白单体,能够检测可溶性血纤蛋白的单克隆抗体,杂交瘤及其单克隆抗体的使用,为早期血凝形成提供灵敏,快速的测量方法。类似于血液纤维蛋白单体的纤维蛋白单体被用作免疫原,并且通过细胞融合方法不与纤维蛋白原反应,并且被包含在天然纤维蛋白单体中。单克隆抗体可同时被识别并鉴定出可溶性纤维蛋白。纤维蛋白单体类似物化合物优选是纤维蛋白原,其用警棍单体相似化合物处理,并用巴曲酶(“ poison”)处理。

著录项

  • 公开/公告号JP4142747B2

    专利类型

  • 公开/公告日2008-09-03

    原文格式PDF

  • 申请/专利权人 日水製薬株式会社;

    申请/专利号JP19990504152

  • 发明设计人 浜野 明栄;梅田 衛;田中 誠司;

    申请日1998-06-19

  • 分类号C07K16/36;C12N5/10;C12P21/08;G01N33/53;G01N33/536;

  • 国家 JP

  • 入库时间 2022-08-21 20:19:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号